Health

RFK Jr. eases access to unproven peptides despite opposition from FDA scientists

The document, primarily written by officials at HHS, faced overwhelming pushback among FDA drug staffers who warned it could undermine the agency’s long-standing mission of keeping unsafe health products off the U.S. market

Katherine Langford